title: Nutritional status of persons with HIV infection, persons with HIV infection and tuberculosis, and HIV-negative individuals from southern India.
abstract: We compared the nutritional status of individuals with human immunodeficiency virus (HIV) infection alone, individuals with HIV infection and tuberculosis (after completion of antituberculosis treatment), and HIV-negative individuals and found that malnutrition, anemia, and hypoalbuminemia were most pronounced among HIV-positive patients with tuberculosis. Weight loss was associated with loss of fat in female patients and with loss of body cell mass in male patients.
authors.affiliation: Tuberculosis Research Centre, Chetpet, Chennai, India. doctorsoumya@yahoo.com
authors.forename: Soumya
authors.initials: S
authors.lastname: Swaminathan
authors.forename: C
authors.initials: C
authors.lastname: Padmapriyadarsini
authors.forename: B
authors.initials: B
authors.lastname: Sukumar
authors.forename: Sheikh
authors.initials: S
authors.lastname: Iliayas
authors.forename: S Ramesh
authors.initials: SR
authors.lastname: Kumar
authors.forename: C
authors.initials: C
authors.lastname: Triveni
authors.forename: P
authors.initials: P
authors.lastname: Gomathy
authors.forename: Beena
authors.initials: B
authors.lastname: Thomas
authors.forename: Minnie
authors.initials: M
authors.lastname: Mathew
authors.forename: P R
authors.initials: PR
authors.lastname: Narayanan
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology; D000328:Adult; D000740:Anemia / Q000150:complications; D000995:Antitubercular Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001823:Body Composition; D004359:Drug Therapy, Combination; D004977:Ethambutol / Q000008:administration & dosage / Q000627:therapeutic use; D015658:HIV Infections / Q000150:complications*; D018023:HIV Seronegativity; D006801:Humans; D034141:Hypoalbuminemia / Q000150:complications; D007194:India; D007538:Isoniazid / Q000008:administration & dosage / Q000627:therapeutic use; D044342:Malnutrition / Q000150:complications*; D009752:Nutritional Status; D011718:Pyrazinamide / Q000008:administration & dosage / Q000627:therapeutic use; D012293:Rifampin / Q000008:administration & dosage / Q000627:therapeutic use; D016896:Treatment Outcome; D014397:Tuberculosis, Pulmonary / Q000150:complications* / Q000188:drug therapy
chemical_list: D000995:Antitubercular Agents; D011718:Pyrazinamide; D004977:Ethambutol; D007538:Isoniazid; D012293:Rifampin